BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7723388)

  • 1. Differential TdT expression in acute leukemia by flow cytometry: a quantitative study.
    Farahat N; Lens D; Morilla R; Matutes E; Catovsky D
    Leukemia; 1995 Apr; 9(4):583-7. PubMed ID: 7723388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
    Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
    Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
    Drexler HG; Sperling C; Ludwig WD
    Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
    Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
    Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
    Paietta E; Meenan B; Heavey C; Thomas D
    Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal transferase in leukemias by flow cytometry.
    Loftin KC; Reuben JM; Dalton W; Hersh EM; Sujansky D
    Diagn Immunol; 1986; 4(3):165-9. PubMed ID: 3460728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia.
    Hurford MT; Altman AJ; DiGiuseppe JA; Sherburne BJ; Rezuke WN
    Am J Clin Pathol; 2008 May; 129(5):700-5. PubMed ID: 18426728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of terminal deoxynucleotidyl transferase.
    Almasri NM; Iturraspe JA; Benson NA; Chen MG; Braylan RC
    Am J Clin Pathol; 1991 Mar; 95(3):376-80. PubMed ID: 1996546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia.
    Gore S; Kastan M; Civin C
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():39-41. PubMed ID: 1697192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of terminal deoxynucleotidyl transferase (TdT) by flow cytometry in leukemic disorders.
    Bardales RH; Carrato A; Fleischer M; Schwartz MK; Koziner B
    J Histochem Cytochem; 1989 Apr; 37(4):509-13. PubMed ID: 2647840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of leukemia cell terminal transferase measurements.
    McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
    Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.
    Kalwinsky DK; Weatherred WH; Dahl GV; Bowman WP; Melvin SL; Coleman MS; Bollum FJ
    Cancer Res; 1981 Jul; 41(7):2877-81. PubMed ID: 7018672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lineage commitment in biphenotypic acute leukemia.
    Buccheri V; Matutes E; Dyer MJ; Catovsky D
    Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)].
    Welte K; Ebener U; Hinderfeld L; Ritter J; Henze G; Kornhuber B
    Klin Padiatr; 1981 May; 193(3):165-71. PubMed ID: 6943391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors.
    Farahat N; Lens D; Zomas A; Morilla R; Matutes E; Catovsky D
    Br J Haematol; 1995 Nov; 91(3):640-6. PubMed ID: 8555067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of TdT positivity in cases of leukemia and lymphoma.
    Drexler HG; Menon M; Minowada J
    Acta Haematol; 1986; 75(1):12-7. PubMed ID: 3088880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.